Post by Perceptive Inc.
51,630 followers
As we look ahead to #AAIC2026, Perceptive’s scientific leaders are eager to share their perspectives on the trends and challenges shaping CNS clinical development. Here, David Cash discusses: 🔹 The evolving role of blood-based biomarkers in Alzheimer's disease trials 🔹 Why imaging remains critical for tracking disease progression and safety 🔹 The challenge of translating academic breakthroughs into globally deployable clinical trial solutions These are exactly the conversations our scientists are prepared to have with sponsors who are advancing the next generation of CNS therapeutics. Watch the video and connect with our experts to discuss the many factors that can influence your imaging strategy and help you achieve your CNS clinical development goals. Schedule a meeting at #AAIC: https://lnkd.in/ev-GEYjH #CNSDrugDevelopment #AlzheimersDisease #Neuroimaging #ClinicalTrials #BiomarkerScience
Video Content